All Posts
News

Epax launches first commercially available VLC-PUFA product

Published on
April 2, 2025
Contributors
Sarah Christianslund
Product Marketing Manager

Epax has launched EPAX® Evolve 05 – the world’s first commercially available VLC-PUFA (very long chain polyunsaturated fatty acid) product. VLC-PUFAs are a family of Omega-3 fatty acids that offer particular potential in the healthy ageing category.

Visit the NovusLipid page to learn more!

‍

Articles

Discover More

Continue exploring the latest stories, research, and breakthroughs from the world of Epax®.

News
5 min read

Epax research paper nominated for BJN Paper of the Year 2024

Epax has achieved a significant milestone with their scientific paper on VLC-fatty acids being nominated by the British Journal of Nutrition for the BJN Paper of the Year 2024.
Read more
News
5 min read

New Laboratory Proficiency Program available from GOED

GOED has launched CS-GOED Nutraceutical Oils Laboratory Proficiency Program (LPP) to enable laboratories to assess their proficiency in quantifying EPA and DHA in omega-3 oils.
Read more
News
5 min read

Next-level distillation technology creates new opportunities for ultra-concentrated Omega-3

The black box-protected technology is the result of years of research and development
Read more
News
5 min read

Epax achieves FSSC2200 certification

This certification is not only proof of our dedication to customer safety and trust but also recognition of our team working tirelessly to meet and exceed the industry's highest standards
Read more